{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:20:03Z","timestamp":1793596803972,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000973","name":"Cystic Fibrosis in Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["AGBORE20Q10"],"award-info":[{"award-number":["AGBORE20Q10"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI DIR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.healun.2022.09.012","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T22:25:00Z","timestamp":1663626300000},"page":"226-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9366-1515","authenticated-orcid":false,"given":"Ananth V.","family":"Charya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Ponor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-2233","authenticated-orcid":false,"given":"Deborah","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Philogene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1657-2877","authenticated-orcid":false,"given":"Moon K.","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-2045","authenticated-orcid":false,"given":"Hyesik","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Mary","family":"Bon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joby","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Luikart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K.","family":"Khush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-2629","authenticated-orcid":false,"given":"Gerald","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6844-209X","authenticated-orcid":false,"given":"Charles","family":"Marboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Orens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-9161","authenticated-orcid":false,"given":"Sean","family":"Agbor-Enoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2022.09.012_bib0001","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","article-title":"National conference to assess antibody-mediated rejection in solid organ transplantation","volume":"4","author":"Takemoto","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0002","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0003","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14990","article-title":"Banff Lung Report: current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR)","volume":"19","author":"Roux","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0004","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/ajt.14893","article-title":"Human leukocyte antigens antibodies after lung transplantation: primary results of the HALT study","volume":"18","author":"Hachem","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01248-2017","article-title":"Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation","volume":"50","author":"Verleden","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.09.012_bib0006","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01898-2017","article-title":"Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome","volume":"52","author":"Brugiere","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.09.012_bib0007","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.healun.2020.09.003","article-title":"Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction","volume":"39","author":"Iasella","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0008","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.healun.2012.11.018","article-title":"Pathologic findings in lung allografts with anti-HLA antibodies","volume":"32","author":"DeNicola","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0009","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/ajt.14534","article-title":"The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation","volume":"18","author":"Aguilar","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-016-1578-9","article-title":"The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review","volume":"21","author":"Gogenur","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.healun.2022.09.012_bib0011","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcrc.2015.10.013","article-title":"Branched DNA-based Alu quantitative assay for cell-free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome","volume":"31","author":"Hou","year":"2016","journal-title":"J Crit Care"},{"key":"10.1016\/j.healun.2022.09.012_bib0012","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(18)30264-9","article-title":"Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial","volume":"6","author":"Wang","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.healun.2022.09.012_bib0013","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1373\/clinchem.2009.129072","article-title":"Cell-free DNA as a noninvasive acute rejection marker in renal transplantation","volume":"55","author":"Garcia Moreira","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.healun.2022.09.012_bib0014","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/TP.0000000000002482","article-title":"Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A systematic review","volume":"103","author":"Knight","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.09.012_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ebiom.2018.12.029","article-title":"Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation","volume":"40","author":"Agbor-Enoh","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.healun.2022.09.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.healun.2022.09.012_bib0017","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-A consensus report from the pulmonary council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0018","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0019","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2022.09.012_bib0020","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study","volume":"40","author":"Jang","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0021","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0022","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","article-title":"Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation","volume":"32","author":"Lobo","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0023","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/ajt.13589","article-title":"Antibody-mediated rejection in lung transplantation: clinical outcomes and donor-specific antibody characteristics","volume":"16","author":"Roux","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0024","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.healun.2014.07.012","article-title":"De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation","volume":"33","author":"Safavi","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0025","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.healun.2013.07.004","article-title":"Acute antibody-mediated rejection after lung transplantation","volume":"32","author":"Witt","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0026","article-title":"Antibody-mediated rejection management following lung transplantation","author":"Neuhaus","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.healun.2022.09.012_bib0027","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.14222","article-title":"Proteasome inhibitor carfilzomib-based therapy for antibody-mediated rejection of the pulmonary allograft: use and short-term findings","volume":"17","author":"Ensor","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.09.012_bib0028","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.healun.2012.11.005","article-title":"Pathology of pulmonary antibody-mediated rejection: 2012 update from the pathology council of the ISHLT","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822021362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822021362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:46:15Z","timestamp":1760949975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249822021362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1053249822021362"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2022.09.012","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2022.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}